Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Data Collection I01:30

Data Collection I

7.8K
Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...
7.8K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

200
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
200

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.

bioRxiv : the preprint server for biology·2026
Same author

Profiling of Both Dipeptidyl Peptidase III and Renin Reveals Higher Mortality in Septic Shock.

Research square·2026
Same author

WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.

NPJ breast cancer·2026
Same author

An improved analytic workflow for serum mtDNA DAMP abundance, fragmentation and heteroplasmic variants: a retrospective analysis of acute respiratory failure patients.

Scientific reports·2026
Same author

Biological subphenotypes in severe acute hypoxaemic respiratory failure and acute respiratory distress syndrome using rapid prospective classification (SPARC) in the USA: a multicentre, observational, study.

The Lancet. Respiratory medicine·2026
Same author

Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer.

European urology focus·2026
Same journal

Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic stroke.

Communications medicine·2026
Same journal

A memory retrieval-aversive conditioning procedure durably reduces gaming craving and fronto-insular activation in internet gaming disorder: a randomized controlled trial.

Communications medicine·2026
Same journal

Intraoperative dexmedetomidine reduces postoperative sleep disturbance in older adults undergoing major abdominal surgery: a single-center, randomized, double-blind, placebo-controlled trial.

Communications medicine·2026
Same journal

The landscape of artificial intelligence in neurodegenerative diseases: a systematic review.

Communications medicine·2026
Same journal

Troponin release and mechanism-dependent myocardial injury in a lightning-induced mass casualty incident.

Communications medicine·2026
Same journal

Integrating a national crisis counseling hotline into Iran's primary health care network to provide rapid mental health support during armed conflict.

Communications medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2

Ali B Abbasi1, Kathleen D Liu1, Derek W Russell2

  • 1University of California San Francisco, San Francisco, CA, USA.

Communications Medicine
|October 30, 2025
PubMed
Summary
This summary is machine-generated.

Source data verification (SDV) in clinical trials is often unnecessary. A COVID-19 trial found that systematic data capture and monitoring, without SDV, maintained data integrity and improved efficiency.

More Related Videos

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

806
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.7K

Related Experiment Videos

Last Updated: Jan 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

806
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.7K

Area of Science:

  • Clinical Trials
  • Data Management
  • Epidemiology

Background:

  • The COVID-19 pandemic necessitated clinical trials with robust primary data capture and reduced reliance on source data verification (SDV).
  • This study evaluates a natural experiment comparing a streamlined data capture approach to traditional SDV.

Purpose of the Study:

  • To assess the quality, cost, and impact of systematic data capture versus traditional SDV in a large COVID-19 clinical trial.
  • To determine if eliminating SDV affects data integrity and trial outcomes.

Main Methods:

  • The I-SPY COVID platform trial (NCT04488081) used daily checklists, lab/medication capture, and centralized monitoring instead of SDV.
  • Retrospective SDV was performed on 30% of patients (333/1,111) and 23% of electronic case report forms (eCRFs) after trial closure.

Main Results:

  • Retrospective SDV resulted in minor data field changes (0.36%) and did not alter recorded outcomes (death, recovery, censored).
  • SDV identified two additional adverse events and shifted recovery dates in 9 instances by a median of 2 days.
  • Retrospective SDV of 23% of eCRFs incurred significant costs: 61,073 person-hours and $6.1 million.

Conclusions:

  • Extensive SDV did not alter the results or conclusions of the I-SPY COVID trial.
  • The trial's systematic data capture and monitoring strategy proved effective, suggesting SDV may be eliminable in similar trials.
  • This approach has the potential to enhance clinical trial efficiency and reduce costs.